Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial R Ladenstein, U Pötschger, MC Le Deley, J Whelan, M Paulussen, ... J Clin Oncol 28 (20), 3284-3291, 2010 | 591 | 2010 |
A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis H Gadner, N Grois, M Arico, V Broadbent, A Ceci, A Jakobson, D Komp, ... The Journal of pediatrics 138 (5), 728-734, 2001 | 588 | 2001 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis H Gadner, M Minkov, N Grois, U Pötschger, E Thiem, M Arico, ... Blood, The Journal of the American Society of Hematology 121 (25), 5006-5014, 2013 | 465 | 2013 |
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia MN Dworzak, G Fröschl, D Printz, G Mann, U Pötschger, ... Blood, The Journal of the American Society of Hematology 99 (6), 1952-1958, 2002 | 456 | 2002 |
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease T Lion, R Baumgartinger, F Watzinger, S Matthes-Martin, M Suda, ... Blood 102 (3), 1114-1120, 2003 | 429 | 2003 |
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification H Gadner, N Grois, U Pötschger, M Minkov, M Aricò, J Braier, V Broadbent, ... Blood, The Journal of the American Society of Hematology 111 (5), 2556-2562, 2008 | 381 | 2008 |
Risk factors for diabetes insipidus in langerhans cell histiocytosis N Grois, U Pötschger, H Prosch, M Minkov, M Arico, J Braier, JI Henter, ... Pediatric blood & cancer 46 (2), 228-233, 2006 | 378 | 2006 |
Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial R Ladenstein, U Pötschger, D Valteau-Couanet, R Luksch, V Castel, ... The Lancet Oncology 19 (12), 1617-1629, 2018 | 310 | 2018 |
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi … R Ladenstein, U Pötschger, ADJ Pearson, P Brock, R Luksch, V Castel, ... The lancet oncology 18 (4), 500-514, 2017 | 300 | 2017 |
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors … C Peters, M Schrappe, A von Stackelberg, A Schrauder, P Bader, W Ebell, ... Journal of clinical oncology: official journal of the American Society of …, 2015 | 252 | 2015 |
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation T Lion, K Kosulin, C Landlinger, M Rauch, S Preuner, D Jugovic, ... Leukemia 24 (4), 706-714, 2010 | 213 | 2010 |
Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study C Peters, JH Dalle, F Locatelli, U Poetschger, P Sedlacek, J Buechner, ... Journal of Clinical Oncology 39 (4), 295-307, 2021 | 208 | 2021 |
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible MN Dworzak, G Gaipa, R Ratei, M Veltroni, A Schumich, O Maglia, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2008 | 202 | 2008 |
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ... The lancet oncology 10 (7), 663-671, 2009 | 194 | 2009 |
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy MN Dworzak, A Schumich, D Printz, U Pötschger, Z Husak, A Attarbaschi, ... Blood, The Journal of the American Society of Hematology 112 (10), 3982-3988, 2008 | 192 | 2008 |
Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator M Minkov, N Grois, A Heitger, U Pötschger, T Westermeier, H Gadner, ... Medical and pediatric oncology 39 (6), 581-585, 2002 | 182 | 2002 |
Langerhans cell histiocytosis in neonates M Minkov, H Prosch, M Steiner, N Grois, U Pötschger, P Kaatsch, ... Pediatric blood & cancer 45 (6), 802-807, 2005 | 173 | 2005 |
Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients C Peters, M Minkov, S Matthes‐Martin, U Pötschger, V Witt, G Mann, ... British journal of haematology 106 (3), 689-696, 1999 | 167 | 1999 |
Persistence and reactivation of human adenoviruses in the gastrointestinal tract K Kosulin, E Geiger, A Vécsei, WD Huber, M Rauch, E Brenner, F Wrba, ... Clinical Microbiology and Infection 22 (4), 381. e1-381. e8, 2016 | 157 | 2016 |
Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies M Minkov, N Grois, A Heitger, U Pötschger, T Westermeier, H Gadner Klinische Pädiatrie 212 (04), 139-144, 2000 | 153 | 2000 |